PBT434 is a potent, orally active and cross the blood-brain barrier alpha-synuclein aggregation inhibitor. PBT434 can be used as a iron chelator and modulates transcellular iron trafficking. PBT434 inhibits iron-mediated redox activity and iron-mediated aggregation of alpha-synuclein. PBT434 prevents the loss of substantia nigra pars compacta neurons (SNpc). PBT434 has the potential for the research of Parkinsons disease (PD)[1].
Molekulargewicht:
383.07
Reinheit:
98.86
CAS Nummer:
[1232841-78-9]
Formel:
C12H14BrCl2N3O2
Target-Kategorie:
alpha-synuclein
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten